维普中文期刊产品整合服务
28篇 您的检索式:作者名="Shakespeare L"
    题名 作者 年代 出处 被引量
1Market reac- tions to the disclosure of internal control weaknesses and to the characteristics of those weaknesses under Section 302 of the Sarbanes Oxley Act of 2002显示文摘Hammersley J S Myers L A Shakespeare C 2008Review of Ac- counting Studies2008,13,1:1
2Market reactions to the disclosure of internal control weaknesses and to the characteristics of those weaknesses under section 302 of the Sarbanes Oxley Act of 2002显示文摘HAMMERSLEY J S MYERS L A SHAKESPEARE C 2008Review of Accounting Studies2008,,13:1
3Market Reactions to the Disclosure of Internal Control Weaknesses and to the Characteristics of Those Weak- nesses Under Section 302 of the Sarbanes Oxley Act of 2002 显示文摘Hammersley J Myers L Shakespeare C 2008Review of Accounting Studies2008,,13:1
4Fair value account- ing and gains from asset securitizations: A convenient earn- ings management tool with compensation side-benefits 显示文摘Dechow P M Myers L A Shakespeare C 2010Journal of Accounting and Economics2010,49,1:1
5Fair Value Ac-counting and Gains from Asset Securitizations : A Conve-nient Earning Management Tool with Compensation Side-Benefits 显示文摘Dechow P M Myers L A Shakespeare C 2010Journal of Accounting and Economics2010,49,12:1
6MarketReactions to the Disclosure of Internal ControlWeaknesses and to the Characteristics of ThoseWeaknesses Under Section 302 of the Sarbanes Oxley Actof 2002显示文摘Hammersley J S Myers L A Shakespeare C 2008Review of Accounting Studies2008,13,:1
7Fair val- ue accounting and gains from asset securitizations: a con- venient earnings management tool with compensation side- benefits 显示文摘DECHOW M P MYERS A L SHAKESPEARE C 2010Journal of Accounting and Economics2010,49,0102:1
8Market reactions to the disclosure of internal control weakness and to characteristics of those weaknesses under section 302 of the Sarbanes Oxley Act显示文摘Hammersley J S Myers L A Shakespeare C 2008Review of Accounting Study2008,13,1:1
9Fair Value Accounting and Gains from Asset Securitizations: A Convenient Earnings Management Tool with Compensation Side-benefits显示文摘Dechow P M Myers L A Shakespeare C 2010Journal of Accounting and Economics2010,49,1:1
10Fair value accounting and gains from asset securitizations: A convenient earnings management tool with compensation side-benefits 显示文摘DECI-1OW P M MYERS L A SHAKESPEARE C 2010Journal of Accounting and Economics2010,49,12:1
11Market Reactions to the Disclosure of Internal Control Weaknesses and to the Characteristics of those Weaknesses under Section 302 of the Sarbanes Oxley Act of 2002显示文摘Hammersley J Myers L Shakespeare C 0,,01:1
12Market Reactions to the Disclosure of Internal Con- trol Weaknesses and to the Characteristics of ThoseWeaknesses under Section 302 of the Sarbanes Ox- ley Act of 2002显示文摘Hammersley J S Myers L A Shakespeare C 2007Review of Accounting Studies2007,13,1:1
13Market reaction to the disclosure of internal control weaknesses and to the characteristics of those weaknesses under Section 302 of the Sarbanes Oxley Act of 2002 显示文摘HAMMERSLEY J S MYERS L A SHAKESPEARE C 2008Review of Ac- counting Studies2008,13,:1
14Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in T1 and T2 nasopharyngeal carcinoma 显示文摘Lu J J Shakespeare T P Tan L K 2004Head Neck2004,26,5:1
15Fair value accounting and gains from asset securitizations : A conven-ient earnings management tool with compensation side- benefit显示文摘Dechow P M Myers L A and Shakespeare C 2010Journal of Accounting and Economics2010,49,12:1
16Market reactions to the disclosure of internal control weakness and to the characteristics of those weaknesses section 302 of the Sarbanes Oxley Act of 2002 显示文摘Hammersley S J Myers A L Shakespeare C 2007Review of Accounting Studies2007,13,:1
17Fair value accounting and gains from asset securitizations: a con- venient earnings management tool with compensation side- benefits显示文摘Dechow P M Myers L A Shakespeare C 2010Journal of Accounting and Economics2010,49,1:1
18Interaction between connex- irdO and mitogen - activated protein kinase signaling in lens homeo- stasis 显示文摘Shakespeare TI Sellitto C Li L 2009Mol Biol Cell2009,20,10:1
19Prospective phase Ⅱ trial of concomitant boost radiotherapy for stage Ⅱ nasopharyngeal carcinoma显示文摘Lu JJ Kong L Shakespeare TP 2008Oral Oncol2008,44,7:1
20Market Reactions to the Disclosure of Internal Control Weaknesses and to the Characteristics of those Weaknesses under Section 302 of the Sarbanes Oxley Act of 2002显示文摘Hammersley J Myers L Shakespeare C 0,,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费